Factors determining change in treatment for ambulatory children with pulmonary arterial hypertension: Implications for monitoring.

ABSTRACT: While care models adapt to the COVID-19 pandemic with virtual and hybrid visits, clinical factors associated with treatment changes among ambulatory pediatric pulmonary arterial hypertension (PAH) patients are not well characterized. To understand which data critically altered treatment recommendations, we conducted a retrospective review among ambulatory children with Group 1 PAH to determine optimal visit and diagnostic strategies. Changes in management included: unplanned new treatments, dose modifications of vasodilators or diuretics, unscheduled hospitalizations, or changes to activity recommendations, catheterization schedule, or other testing. Factors prompting management changes were classified as symptoms, exam findings, or diagnostic tests. Across 398 ambulatory visits by 48 pati

SUBMITTER: Critser PJ 

PROVIDER: S-EPMC9382461 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature